NCT06147882

Brief Summary

Fibromyalgia (FM) is characterized by symptoms such as chronic widespread pain, severe fatigue, sleep disturbances, extremity paresthesia, stiffness, mood disturbances, and cognitive impairment lasting more than 3 months without an alternative explanation. Although the exact etiology and pathogenesis of FM is still unknown, it has been suggested that stress or psychological factors may play a key role in the syndrome. 1,2,3 Positive Psychotherapy supports individuals in symptom management to use their resources to overcome difficulties, understand and recognize growth areas with a therapeutic approach.4 In this respect, it overlaps with the professional purpose of mental health and psychiatric nursing (RSPH). The aim of this study; In this study, it is aimed to report the process of examining the pain perception, daily life activities and mental health of patients with fibromyalgia syndrome (FMS) and the effectiveness of the psychoeducation program based on Positive Psychotherapy (PPT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 6, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 28, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2024

Completed
Last Updated

August 12, 2024

Status Verified

August 1, 2024

Enrollment Period

7 months

First QC Date

October 6, 2023

Last Update Submit

August 9, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Pain Perception of Fibromyalgia Syndrome Patients from Baseline

    Pain will be used to evaluate by VAS (Visual Anolog Scale) Line: A horizontal line is usually used, with the left end representing one extreme (e.g., "no pain" or "not at all") and the right end representing the other extreme (e.g., "worst pain imaginable" or "extremely intense"). Length: The line is typically 100 millimeters long Participants are provided with instructions explaining what the scale measures (e.g., pain intensity) and are asked to mark a point on the line that best represents their experience. Scoring: Measurement is done by measuring the distance in millimeters from the left end of the line to the point marked by the participant. This provides a numerical score that quantifies the individual's perception. Interpretation: A higher score on the VAS generally indicates a more intense or severe experience of the measured phenomenon.

    Pre-test (Before positive psychotherapy group intervention), Post- test (10 weeks after therapy) and Follow up (12 weeks after therapy)

  • Change in daily living activities of fibromyalgia patients from baseline

    Fibromyalgia Impact Questionnaire The Fibromyalgia Impact Questionnaire (FIQ) is a self-administered questionnaire designed to assess the health status and impact of fibromyalgia on individuals. It was developed to provide a comprehensive overview of the various aspects of fibromyalgia, including physical functioning, symptoms, and overall well-being. Physical Functioning: Work Status: Questions address how fibromyalgia affects an individual's ability to work. Depression and Anxiety: The FIQ includes questions about emotional well-being, assessing symptoms of depression and anxiety. Morning Tiredness: Measures the level of fatigue and tiredness experienced in the morning, providing insights into the impact of fibromyalgia on sleep and morning functioning. Pain Levels: Questions related to the intensity of pain experienced by individuals with fibromyalgia. Stiffness: Assesses the extent of stiffness experienced by individuals, which is a common symptom of fibromyalgia.

    Pre-test (Before positive psychotherapy group intervention), Post- test (10 weeks after therapy) and Follow up (12 weeks after therapy)

Secondary Outcomes (1)

  • Change in the mental health of fibromyalgia patients from the beginning

    Pre-test (Before positive psychotherapy group intervention), Post- test (10 weeks after therapy) and Follow up (12 weeks after therapy)

Study Arms (2)

Psychoeducation Group

ACTIVE COMPARATOR

The group of patients who are given psychoeducation program

Behavioral: The group will include patients with fibromyalgia syndrome who will receive positive psychotherapy.

Control Group

NO INTERVENTION

The group of patients who are not given psychoeducation program

Interventions

The group will include patients with fibromyalgia syndrome who will receive positive psychotherapy.

Psychoeducation Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between the ages of 18-65,
  • Having been diagnosed with Fibromyalgia Syndrome according to the 2016 ACR diagnostic criteria for at least 1 year,
  • Agreeing to participate in the study.

You may not qualify if:

  • Those in acute depression
  • History of a recent cardiac event such as myocardial infarction,
  • History of significant head trauma,
  • Peripheral neuropathy,
  • Use of some centrally acting analgesic drugs such as opioids,
  • History of substance and alcohol abuse,
  • Concomitant autoimmune or inflammatory disease,
  • Diseases affecting the central nervous system (for example, multiple sclerosis, Parkinson's disease),
  • Serious psychiatric conditions that prevent participation (for example, psychotic disorders).
  • Previously, therapy, counseling, personal development, etc. to have received

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Düzce Üniversitesi

Düzce, 81620, Turkey (Türkiye)

Location

Related Publications (1)

  • Erol H, Karaca A. The Effect of Positive Psychotherapy on Pain Perception, Daily Functioning, and Mental Health in Patients With Fibromyalgia. Pain Manag Nurs. 2025 Dec;26(6):e550-e560. doi: 10.1016/j.pmn.2025.07.007. Epub 2025 Sep 4.

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

October 6, 2023

First Posted

November 28, 2023

Study Start

July 1, 2023

Primary Completion

January 12, 2024

Study Completion

May 21, 2024

Last Updated

August 12, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations